Efficiency of bortezomib and dexamethasone in relapsed multiple myeloma treatment: Retrospective study in consecutive cases;Efectividad de bortezomib y dexametasona en el tratamiento de mieloma múltiple refractario: Estudio retrospectivo de una serie de casos consecutivos

Anales de Medicina Interna

Volumn 25, Issue 2, 2008, Pages 73-77

  Khosravi Shahi, Parham ^a   Sabin Dominguez P ^a   Encinas Garcia S ^a   Izarzugaza Peron Y ^a   Perez Manga G ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Bortezomib; Dexamethasone; Myeloma; Progression free survival; Response rate

Indexed keywords

BORTEZOMIB; DEXAMETHASONE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; NAUSEA; NEUROPATHY; NEUROTOXICITY; NEUTROPENIA; RETROSPECTIVE STUDY; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; DEXAMETHASONE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PYRAZINES; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 43549102621     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (16)